- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00473421
"How do Contrast Medias in Bone Cement Affect DXA Measurements After THR"
Joint replacement is a well-documented and cost effective treatment of degenerative diseases in the hip (1,2). There are two different principles of fixation of prosthesis components; cemented and uncemented. The most common mode of fixation in Scandinavia has historically been with bone cement. In the recent years a reverse hybrid combination (uncemented stem and cemented cup) is gaining popularity, especially in Norway.
Beside luxation, infection and venous thromboembolism, the problem with aseptic loosening is a known complication. A marker for aseptic loosening is local bone loss around the components. This is measured with a densiometer and the method is Dual Energy X-ray Absorbtiometry (DXA). Periprosthetic bone loss is evaluated by series of DXA scans around the components over time. This enables us to follow changes in bone mineral density (BMD) close to the prosthesis.
We want to compare cemented and uncemented prostheses with this technique. This is a problem since we don't know how much different contrast medias in bone cement affect DXA scans. This area is poorly investigated. Attempts have been made to exclude the cement-mantle from the measurements both digitally and manually, but these have showed poor precision. A kind of consensus of assuming that contrast medias in bone cement give an increase in measured BMD of 20% (4). This is used when comparing cemented and uncemented components.
We have preformed laboratory tests of different cements. Zirconium oxide (ZrO2) and Barium sulphate (BaSO4) are used as radiopacifiers. These contrast medias have different properties. Our test showed that Zirconium give 63% higher BMD when we scanned cement alone.
This is supported by a cadaver study showing significant differences between contrast free cement and ZrO2 /BaSO4 containing cements.
It is our opinion that it is necessary to perform a prospective study to investigate this more thoroughly.
The hypothesis of this study is that it is not accurate enough to add 20% in BMD for cemented implants when comparing them with uncemented implants. It is probably necessary to take into account the amount of cement used and kind of contrast medium.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
-
Oslo, Norway, 0407
- Recruiting
- Ullevaal University Hospital
-
Contact:
- Jon Dahl, MD
- Phone Number: 91848655
- Email: jon.dahl@mac.com
-
Contact:
- Jon Dahl
- Phone Number: 91848655
- Email: jon.dahl@mac.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Osteoarthritis
Exclusion Criteria:
- more than 80 yrs
- systemic disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Lars Nordsletten, MD Ph.D, Ullevaal University Hospital
- Principal Investigator: Jon Dahl, MD, Ullevaal Univerity hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Human sementstudie
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary and Secondary Osteoarthritis in Hip
-
Johan KarrholmCompletedPrimary Osteoarthritis of Hip Nos | Secondary Osteoarthritis of Hip
-
Sahlgrenska University Hospital, SwedenZimmer BiometActive, not recruitingSurgical Treatment | Primary Hip Osteoarthritis | Secondary Hip Osteoarthritis Due to Idiopathic Femoral Head Necrosis, Childhood or Inflammatory Disease | Bilateral Hip Disease
-
Smith & Nephew Orthopaedics AGCompletedAvascular Necrosis | Primary Osteoarthritis | Secondary Osteoarthritis | Primary Total Hip Replacement (THR)United Kingdom
-
University Hospital, BrestRecruitingCoxarthrosis; Primary | Coxarthrosis; SecondaryFrance
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioRecruitingOsteoarthritis, Knee | Osteoarthritis, Hip | Osteoarthritis Secondary | Osteoarthritis PrimaryItaly
-
CrystalGenomics, Inc.CompletedLocalized Primary Osteoarthritis of Hip | Localized Primary Osteoarthritis of KneeKorea, Republic of
-
Centre Hospitalier Universitaire DijonUnknown
-
Medacta International SAActive, not recruitingRheumatoid Arthritis | Avascular Necrosis | Congenital Hip Dysplasia | Primary Osteoarthritis | Secondary Osteoarthritis | Traumatic Arthritis | Fracture; Femur, HeadFrance
-
Duke UniversityTerminatedPain | Hip Osteoarthritis | Primary Total Hip ArthroplastyUnited States
-
Massachusetts General HospitalWithdrawnOsteoarthritis of Hip | Failure of Primary THAUnited States
Clinical Trials on Barium Sulphate and Zirconium Oxide
-
BranemarkklinikenRecruiting
-
Medical Research CouncilCompletedIron Deficiency AnaemiaUnited Kingdom
-
Centre Hospitalier Universitaire de NiceUnknown
-
Unidad de Investigacion Medica en Epidemiologia...Fondo para el Fomento a la Investigacion Medica; Doctorado en Farmacologia...Completed
-
Mayo ClinicCompleted
-
Karolinska InstitutetAstraZenecaCompletedChronic Kidney Disease Stage 5 | Hyperkalemia | Chronic Kidney Disease stage4Sweden
-
AstraZenecaRecruitingHyperkalaemiaChina, Germany, United States, Ukraine, Spain, Japan, United Kingdom, Canada, Poland, Romania, Russian Federation, Brazil
-
Eurofarma Laboratorios S.A.CompletedOsteoarthritis of the KneeBrazil
-
VA Caribbean Healthcare SystemCompleted
-
Mayo ClinicCompleted